Sophie Pouplin

Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry

Florence Tubach, Dominique Salmon, Philippe Ravaud et al. · Arthritis & Rheumatism · 2009 · 628 citations · Full text

Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA)

Maxime Dougados, Martin Soubrier, Élodie Perrodeau et al. · Annals of the Rheumatic Diseases · 2014 · 157 citations · Full text

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial

Anna Moltó, Clementina López‐Medina, Filip Van den Bosch et al. · Annals of the Rheumatic Diseases · 2021 · 99 citations · Full text

The burden of pain in rheumatoid arthritis: Impact of disease activity and psychological factors

Pascale Vergne‐Salle, Sophie Pouplin, Anne‐Priscille Trouvin et al. · European Journal of Pain · 2020 · 92 citations · Full text

Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction

Gaëlle Clavel, Natacha Bessis, Delphine Lemeiter et al. · Clinical Immunology · 2007 · 80 citations

Immunology, Pathology, Joint Destruction +18